The Board Chairs of Friends of the Global Fund Europe, Japan, and the United States, as well as the President of the Board of the
In conjunction with the launch of the Global Fund’s new Results Report, which showcases the devastating impact of COVID-19 on the fight against HIV/AIDS, tuberculosis
“Over the past three months, three different commissions issued reports proposing major reforms of the global health architecture to improve pandemic preparedness and response (PPR).
Jeffry Acaba (second from right, sitting down) attending a Joint United Nations Programme on HIV/AIDS meeting, 2017. The latest installment of the “Infectious Diseases Without
Members of akta. Second from the right is Kohta Iwahashi. Photo courtesy of akta. In recognition of this week’s convening of the 2021 United Nations
Noriyuki Ishiyama of the Japan Center for International Exchange (JCIE) / Friends of the Global Fund, Japan (FGFJ) was selected as a torchbearer for the
Maurine Murenga speaking as a Panelist at a Global Fund Resource Mobilization Meeting in Germany for the 5th Replenishment. In this latest issue of the
FGFJ’s 32nd Diet Task Force meeting featured Peter Sands, the executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), as
On April 16, 2021, President Joseph Biden of the United States and Prime Minister Yoshihide Suga of Japan held a meeting in Washington DC. This
The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) and FGFJ have come together to produce an animated video in Japanese introducing the roles and impacts of the Global Fund and it’s partnership over the past 20 years in the fight against the three major infectious diseases globally.
Mark Dybul discusses the Global Fund’s work on controlling the three major infectious diseases at the FGFJ Diet Task Force breakfast meeting. ©FGFJ 2015 This
The Friends of the Global Fund, Japan (FGFJ) and Asahi GLOBE+ are pleased to introduce Dr. Zolelwa Sifumba, a young physician from South Africa, in the second installment of our interview series, “Infectious Diseases Without Borders–Our Story.”
